Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

29 min ago | Vallejo Times-Herald

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Collinsville, IL

29 min ago | WTHR-TV Indianapolis

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Natural Disasters, Wildfire, Fire

29 min ago | Customer Interaction Solutions

Pfizer Reports Second-Quarter 2014 Results

Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment ; the Global Vaccines, Oncology and Consumer Healthcare segment ; ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

1 hr ago | The Globe and Mail

Pfizer beats forecasts as cancer medicine sales grow

The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York, on May 4, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Associated Press

3 hrs ago | Benzinga

Stocks To Watch For July 29, 2014

Wall Street expects Pfizer to report its Q2 earnings at $0.57 per share on revenue of $12.46 billion.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Trucking, United Parcel Service, Air Courier, Transportation, Travelers Express Company, Financial Services, Fresh Del Monte Produce, Agriculture

Mon Jul 28, 2014

Wall Street Journal

Wanted: Startups in Biotech

The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Healthcare Industry, Eli Lilly, Opinion

Seeking Alpha

The Product Development Story Of Provectus Biopharmaceuticals

When Provectus Biopharmaceuticals Inc. announced at the end of May that the FDA had denied it Breakthrough Therapy Designation it caused a sharp drop in the stock price.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry

Seeking Alpha

Whisper Number Impact: How Will Pfizer's Stock Move After Earnings?

Pfizer has a 59% positive surprise history . The overall average post earnings price move is 'positive' when the company reports earnings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Barron's

Pfizer Dips On BMO Downgrade

So concludes BMO Capital Markets today in a downgrade report, which sent shares of Pfizer down nearly 1% to $29.86.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Health, Pain, Enbrel, Etanercept (generic), Celebrex, Celecoxib (generic), Arthritis

Forbes.com

Interesting November Stock Options for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

TheStreet.com

Will This Analyst Downgrade Hurt Pfizer (PFE) Stock Today?

Separately, TheStreet Ratings team rates PFIZER INC as a "buy" with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate PFIZER INC a BUY.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

American Reporter

One Woman's WorldLIFE Can Become Too Quiet

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Sun Jul 27, 2014

Reuters

Pfizer's need for deal looms larger with earnings report

Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Bristol Myers Squibb, Cancer, Health, Breast Cancer

Benzinga

Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More

The earnings crunch continues, and reports so far have generally been encouraging.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

Sat Jul 26, 2014

Benzinga

Weekly Preview: FOMC In Focus, As Earnings Season Progresses

The US Federal Open Market Committee is set to have a two-day policy meeting next week against a backdrop of geopolitical tension and the US earnings season.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Exxon Mobil, Energy, Oil & Gas, ExxonMobil Chemical, Chemicals

Fri Jul 25, 2014

Bloomberg

Puma's Auerbach Gained on Pfizer's Breast Drug Retreat

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Science / Technology, Health, Breast Cancer, Healthcare Law, Law, Johnson and Johnson

Forbes.com

The Debate On Shareholder Value Gets Political

Two months ago, I explained how the single-minded pursuit of making money for shareholders has driven companies like Pfizer [PFE] to try to lower their taxes by moving their legal headquarters to another country-the so-called practice of "inversion"-even if the move harms customers and patients: Does Pfizer Hate Patients? .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

Thu Jul 24, 2014

Seeking Alpha

JNJ: Another Win Added To The Earnings Season

JNJ reported a 2.4% increase in its consumer segment revenue, led by a 9% rise from over the counter drugs, including Tylenol.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Aria Systems, Washington, PA, Fort Washington, PA

SFGate

This Eye-Popping Chart Of Ex-US Companies Shows Why People Are...

This Eye-Popping Chart Of Ex-US Companies Shows Why People Are Freaking Out About 'Tax Inversions' A tax inversion is a corporate merger strategy that involves a company based in one country, say the U.S., acquires another company based somewhere else, say the U.K., and following the deal moves its tax base to enjoy a lower corporate tax rate.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech

Reuters

UPDATE 3-Lilly beats forecasts, vows to remain independent

Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Osteoporosis, Health, Schizophrenia

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••